As of 2024-12-14, the Intrinsic Value of Elanco Animal Health Inc (ELAN) is
2.07 USD. This ELAN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 12.10 USD, the upside of Elanco Animal Health Inc is
-82.86%.
ELAN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(378.08) - (33.20) |
(53.70) |
-543.8% |
| DCF (Growth 10y) |
(31.73) - (318.28) |
(48.85) |
-503.8% |
| DCF (EBITDA 5y) |
(18.56) - (20.55) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(19.08) - (21.00) |
(1,234.50) |
-123450.0% |
| Fair Value |
2.07 - 2.07 |
2.07 |
-82.86% |
| P/E |
11.25 - 12.76 |
12.11 |
0.1% |
| EV/EBITDA |
12.34 - 47.85 |
21.24 |
75.5% |
| EPV |
25.39 - 37.00 |
31.19 |
157.8% |
| DDM - Stable |
4.50 - 40.48 |
22.49 |
85.9% |
| DDM - Multi |
(17.54) - (125.57) |
(31.05) |
-356.6% |
ELAN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
5,981.64 |
| Beta |
1.47 |
| Outstanding shares (mil) |
494.35 |
| Enterprise Value (mil) |
9,848.63 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.64% |
| Cost of Debt |
5.00% |
| WACC |
6.06% |